4.4 Article

Impact of Sleepiness and Sleep Deficiency on Public Health-Utility of Biomarkers

期刊

JOURNAL OF CLINICAL SLEEP MEDICINE
卷 7, 期 5, 页码 S6-S8

出版社

AMER ACAD SLEEP MEDICINE
DOI: 10.5664/JCSM.1340

关键词

-

资金

  1. Cephalon
  2. Koninklijke Philips Electronics
  3. N. V., ResMed
  4. Brigham and Women's Hospital
  5. advisory board of Actelion
  6. Bombardier
  7. Boston Celtics
  8. Delta Airlines
  9. Eli Lilly
  10. Garda Siochana Inspectorate
  11. Global Ground Support
  12. Johnson Johnson
  13. Timberwolves
  14. Norfolk Southern
  15. Portland Trailblazers
  16. Respironics
  17. Sepracor
  18. Sleep Multimedia
  19. Somnus Therapeutics
  20. Vanda Pharmaceuticals
  21. Zeo
  22. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R13HL104874] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Sleep disorders and sleep deficiency are important causes of adverse health effects and increased mortality in the United States and worldwide. Sleep deficiency can also result in myriad adverse behavioral consequences, including profound sleepiness, cognitive slowing, automatic behavior, attentional failures and performance degradation, errors, and accidents. It is important to recognize that sleepiness and sleep definciency are not synonymous.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据